pressed cell-mediated immunity (1). Therefore, the 
mechanisms including fetal anemia (11) (12) (13) (14) (15) and fetal diagnosis of fetal viral infection was evaluated using oligonucleotide primers designed to amplify tal heart failure. An infectious etiology is documented by viral culture or serologic methods in 5-nucleic acid sequences from seven different viruses including CMV, parvovirus, adenovirus, enterovi-15% of cases of fetal hydrops; in up to 22% of cases, the underlying cause is unknown (12, 13) . Fetal parrus, HSV, Epstein-Barr virus (EBV), and respiratory syncytial virus (RSV). These viruses are comvovirus infection causes nonimmune hydrops secondary to severe fetal anemia due to suppression of mon, are known to cause either fetal infection or myocarditis in infants and children, and infect indifetal erythroid progenitors (16); myocarditis has also been reported (17). Infections with other viruses viduals with marginal immune system function. such as CMV (18, 19) or HSV (20) , and more rarely with enteroviruses (14) or adenoviruses (15), are also
MATERIALS AND METHODS reported to cause hydrops fetalis. With the recent
Patient Population advances in viral therapy and fetal medicine, some of these infections are now amenable to supportive or Samples were obtained after written informed specific prenatal treatment (15, 17, 21, 22) . Therefore, consent from mothers of 303 fetuses considered to rapid and accurate identification of the causative vibe at risk for intrauterine viral infection. A variety rus is increasingly important as a guide to prenatal of clinical presentations were used for inclusion crimanagement.
teria, including nonimmune fetal hydrops diagnosed The detection of a fetal viral infection usually reby prenatal ultrasound, fetal pleural effusion, lies on documentation of maternal and fetal sero-''stuck-twin'' or presumed twin-to-twin transfusion conversion for the specific virus and isolation of the syndrome, fetal ventriculomegaly, fetal intracranial virus from fetal body fluids, amniotic fluid, or aucalcification/microcephaly, fetal hepatic calcification topsy specimens. However, serological diagnosis or echogenic bowel, fetal myocarditis, maternal exmay lack sensitivity and can be difficult to interpret.
posure to virus, polyhydramnios, oligohydramnios, In addition, a second convalescent sample 2-3 IUGR, or combinations of these presentations. The weeks after the initial study is required for diagnomean gestational age at presentation and sample sis. Culture and subsequent identification of the vireferral was 18 weeks with a range of 15 to 35 weeks. rus is the ''gold standard'' of diagnosis, but this Control samples (n Å 154) were obtained after inmethod is also generally slow, sometimes taking beformed consent at gestational ages ranging between tween 1 and 3 weeks to obtain a positive result. In 14 and 22 weeks, generally at the time of genetic addition, certain viruses (e.g., parvovirus B19), do amniocentesis in patients presumably at low risk for not readily grow in standard culture systems (23).
the presence of a viral infection. The limited availability of specimens for study of a suspected fetal infection commonly restricts the Sample Material search to only a few probable causative viruses. Finally, the serologic diagnosis assumes a sustained Sample material (n Å 371) was obtained for PCR analysis from ''at risk'' patients (n Å 303) at 34 medifetal immunologic response, yet several case reports demonstrate this is untrue (24, 25) .
cal centers and included amniotic fluid (n Å 253), fetal blood obtained by cordocentesis (n Å 42), cord Recent advances in molecular genetic diagnostic techniques, namely in situ hybridization (26) and blood obtained at the time of delivery (n Å 18), fetal ascites (n Å 8), pleural effusion (n Å 10), and tissue the polymerase chain reaction (PCR) (27, 28) permit rapid detection of viral nucleic acid in a variety of samples (n Å 40), including 19 placental biopsies at the time of delivery. Other tissue samples received infected tissues and body fluids (15,29-35) from adults, children, and fetuses. Detection of fetal infecincluded autopsy specimens such as heart (n Å 12), lung (n Å 5), and fetal liver (n Å 4). tion with CMV, toxoplasmosis, adenovirus, and human parvovirus B19 (36) (37) (38) has already been rePrenatally acquired samples were obtained during invasive diagnostic procedures (amniocentesis, corported. In addition, PCR has been used to identify infection with a number of different viruses in adults docentesis, aspiration of other fetal body fluid accumulations) performed as part of an evaluation of eior children with myocarditis and dilated cardiomyopathy (39) (40) (41) (42) (43) .
ther abnormal ultrasound findings or maternal exposure to viral infection. Fetal blood (2-4 ml) was In this study, the usefulness of PCR in the prena-collected in sodium heparin collection tubes; body sixth primer pair was designed to amplify a 375-bp amplimer from the EcoRI B fragment of EBV (49) . fluid (2-4 ml) and amniotic fluid (2-4 ml) samples were collected in sterile vials and transported either Finally the seventh primer set was designed to amplify a 391-bp RT-PCR amplimer from the F-glycoon ice or at room temperature before being stored at 4ЊC until analysis. Tissue specimens obtained at protein of RSV, with a 207-bp product amplified by internal nested primers (50) . In addition, a primer autopsy were formalin-fixed in the usual manner. Placental samples or other tissue specimens were pair was designed to detect sequences from K-ras, a constitutive component of all tissues. A sequence frozen in liquid nitrogen (44) or analyzed after formalin-fixation. Viral culture and serology was obspanning the 12th codon of K-ras which amplifies a 135-bp product was selected (49) In order to demonstrate successful PCR amplifiamniocentesis from 154 patients with structurally cation, all samples were analyzed with positive connormal fetuses. These patients had no history sugtrol viral nucleic acid; contamination was excluded gestive of a viral syndrome during pregnancy and by the lack of amplified product in a negative control were thus classified as low risk for fetal viral infecsample ( Fig. 1 ). All negative control amplifications tion. These samples served as ''negative patient conwere performed in the same reaction mixture used trols'' and were analyzed in blinded fashion concurfor positive controls and patient samples, but were rent with the other ''diagnostic'' samples.
devoid of nucleic acid template.
Nucleic Acid Extraction
Template Preparation and PCR Tissue samples were homogenized in RNAzol (45) using a Brinkmann Polytron homogenizer prior to Total RNA and DNA were isolated simultaneously nucleic acid extraction as previously described (42) .
from patient specimens using a modification of the Fluid specimens did not require homogenization and RNAzol method first described by Chomczynski and were extracted directly. Total RNA and DNA was Sacchi (69,70) as previously described (68,71,72). isolated simultaneously from patient specimens usTris-saturated phenol (pH 6.6) RNAzol solution was ing the method initially described by Chomcyznski used in simultaneous isolation of both RNA and and Sacchi (45) and subsequently modified (42, 43) .
DNA, which was performed as follows.
Reverse transcriptase-PCR (RT-PCR) was employed Primer Design and Synthesis
to evaluate the RNA viruses, including the enteroviruses, and RSV. First strand cDNA, for use in detection Oligonucleotide primer pairs were prepared on an oligonucleotide synthesizer (Applied Biosystems, Inof enterovirus, was generated from 3 mg of extracted total RNA in the presence of 20 units of an RNase corporated model 380) using published viral sequences (Table 1) . One primer pair was designed to inhibitor, RNasin (Amersham International). This mixture was heated to 95ЊC for 5 min then cooled in ice. amplify a 151-bp region of the 5-untranslated region conserved among all enteroviruses (including CoxTo each reaction was added 5 pmol of primer no. 195, 4 ml of 5 mM each dNTPs, 4 ml of 5x reverse transcriptase sackie viruses and Echovirus), with the exception of echovirus 22 and 23 (46) . A second primer pair, buffer (51 buffer Å 15 mM MgC12, 50 mM dithiothreitol, 250 mM Tris, pH 8.3, and 375 mM KCl), 200 units designed to amplify a 607-bp product was created from the immediate early gene of the AD169 strain of Maloney murine leukemia virus (MoMLV) reverse transcriptase (BRL-Gibco), and DEPC-treated dH 2 O to of CMV, recognizing all CMV serotypes (33) . The third primer pair was designed to amplify a 308-20 ml; this reaction was incubated at 37ЊC for 1 h. Two microliters of this first-strand cDNA or 500 ng of control bp sequence of the hexon region of all adenovirus serotypes (except adenovirus 40,41) (29). The fourth genomic DNA was combined with 25 pmol of each enterovirus primer, 5 ml 101 PCR buffer (100 mM Tris, primer pair amplifies a 241-bp product for HSV-2 or 229-bp product for HSV-1 (47), and the fifth primer pH 8.3, 500 mM KCl, and 15 mM Mg12); and 5 ml 2 mM dNTPS each in a 50-ml reaction volume. Taq pair amplifies a 699-bp sequence of the parvovirus genome, encoding the VP1 capsid protein (48). The polymerase (Perkin-Elmer-Cetus) was added (2.5 units) after an initial 5-min incubation at 95ЊC. Thirtyunits (Perkin-Elmer, Branchburg, NJ), was added after an initial incubation at 94ЊC for 3 min. Thirtyfive (35) rounds of amplification were performed under the following conditions: 95ЊC for 30 s, 57ЊC for 30 s, three rounds of amplification were carried out at the following conditions: 94ЊC 1 2 min, 42ЊC 1 2 min, and 72ЊC for 1 min using a Perkin-Elmer-Cetus Thermocycler or Biometra Thermocycler. The same proceand 72ЊC 1 3 min (72ЊC 1 7 min extension). All samples were run with a simultaneous positive dure was used for RSV genome amplification.
For adenovirus, CMV, HSV, and EBV (i.e., DNA and negative control (i.e., reaction mixture without sample nucleic acid) for the virus analyzed. If a band viruses), 3 ml or 1000 ng, of extracted viral DNA was combined with 25 pmol of appropriate primer, 5 ml was visualized in the negative control lane, the PCR sample was considered contaminated and the sam-101 PCR buffer, and 5 ml 2mM dNTPS, each in a 50-ml reaction volume. Taq polymerase (2.5 units) ple was reanalyzed. All samples were run without knowledge of the clinical, culture, or serologic data, was added after an initial 5-min incubation at 95ЊC. Forty (40) rounds of amplification were performed and were performed in duplicate. For the PCR amplimer to be considered positive, reproducibility of at the following conditions: 95ЊC for 30 s, 57ЊC for 30 s, and 72ЊC for 1 min. For HSV, the conditions the product was required. Control PCR amplification to verify the presence of amplifiable nucleic acid exwere 95ЊC for 1 min, 61ЊC for 1 min, and 72ЊC for 1 min, using 32 rounds of amplification. Ten microlitracted from each sample was performed using primers designed to amplify cellular nucleic acid; K-ras ters of each reaction was analyzed on a 1% ME agarose gel (FMC Biochemicals) or 3% Nu Sieve agarose primers were chosen. If the K-ras primers failed to amplify the appropriate 135-bp amplimer, the sam-(FMC Biochemicals) and 0.5% ME agarose gel containing 0.5 mg/ml of ethidium bromide (Sigma). The ple was reextracted or excluded. Southern blotting and hybridization, as well as direct sequencing of the gels were then placed under UV light for visualization of the amplified products.
PCR product, were used to confirm positive results. Parvoviral target DNA sequences were amplified Viral PCR Electrophoresis in a total reaction volume of 100 ml containing 100 mM each dNTPs, 1 mM each of primers, 10 ml 101
Ten milliliters of each reaction was analyzed on a 1% ME agarose gel (FMC Biochemicals) containing PCR buffer, and 3 ml sample. Taq polymerase, 2.5 Amniotic fluid was positive for one or more viral genomes in 95 of 233 samples (41%), while fetal blood was positive in 13 of 60 samples (22%). The 0.5 ml of ethidium bromide/ml of gel. The gels were PCR was also positive in 6 of 18 pleural fluid samples placed under UV light for visualization of the ampli-(31%) and 10 of the 20 (50%) ascites samples. From fied products. All samples were electrophoresed the samples obtained at delivery or at autopsy, a alongside a reference sizing ladder and a positive PCR-positive result was found in 5 of 19 placental and negative control for the virus being analyzed. If biopsies (26%) and in 10 of 11 samples (91%) oba band was visualized in the negative control lane, tained from the right ventricle. A single sample obthe PCR sample was considered contaminated and tained from the left ventricle did not amplify viral the process repeated. All samples were analyzed genome. Five of 9 samples (56%) obtained from other without prior knowledge of clinical history or laboraorgans (such as liver and lung) were PCR-positive. tory data results. PCR was considered positive only Several patients had multiple sample sources (i.e., if the results could be duplicated. Southern blotting amniotic fluid plus tissue specimens, etc.) analyzed and hybridization (51,52), as well as direct sequencconcomitantly. In some, viral amplification occurred ing of the PCR product (53), were used to confirm in only one sample (i.e., amniotic fluid positive, blood positive results. K-ras PCR was performed with each negative, etc.). Most of these discordant findings ocextraction. curred when amniotic fluid was positive while the fetal blood or ascites was negative.
RESULTS
Nonimmune hydrops were associated with a high incidence of viral infection (50/91 patients) and adeClinical Diagnosis novirus ( Fig. 1 ) was detected in 30 (60%) of these patients (Table 3 ). Adenovirus was also frequently A total of 371 fetal samples obtained from 303 pregnant patients with an abnormal ultrasound or amplified from ascites, pleural effusions, and miscellaneous tissues (i.e., myocardium). at risk for intrauterine fetal viral infection were analyzed by PCR. The clinical characteristics and rea-CMV was associated with a broad range of sonographic abnormalities including nonimmune hysons for referral for viral PCR analysis are listed in Table 2 . The largest single referral diagnosis was drops (Fig. 2) , echogenic bowel, hepatic calcification, growth restriction, ''stuck twin'' syndrome, ascites, terovirus. The enteroviral genome was commonly found in ''stuck twin'' syndrome (where it was the and maternal infection with CMV. In most cases of CMV infection, other viruses were also concomisingle most common genome amplified), myocarditis, ascites with pericardial effusion, hydramnios, and tantly identified, particularly adenovirus and ennonimmune hydrops (Fig. 3) . Although less frequently identified, HSV (n Å 9) and parvovirus (n Å 8) were associated with predict- virus in this series, occurring twice as often as CMV (24 vs 10%). Also unexpectedly, the enteroviral genome was amplified frequently, being detected in 7% of patients. Enteroviruses, especially Coxsackievirus, are common causes of myocarditis in neonates and older children (39) (40) (41) 54 ). Adenoviruses and, less frequently, CMV and HSV have also been reported to cause myocarditis using traditional methodologies (54-57). With the application of molecular-based techniques such as PCR (15,27,28, [39] [40] [41] [42] [43] and in situ hybridization (58-60), it has become apparent that both the relative incidence of myocardial explained by the low sensitivity of standard viral culture methods and serology for many of these viruses. Enteroviral infections have occasionally been able clinical findings. Nearly all cases of parvovirus reported to cause hydrops, and there are reports of (7/8) were found in fetuses with nonimmune hydrops newborns with enteroviral myocarditis diagnosed so (Fig. 4) , while those fetuses with HSV infection had early in life that the infection could only have been either nonimmune hydrops (4/9) or ''stuck twin'' syncontracted during the intrauterine period or during drome (2/9). passage through the birth canal (61-63). To our knowledge, there have been only two cases reported PCR Analysis of Control Patients of prenatally acquired adenoviral myocarditis (15,54), one of which was diagnosed by PCR; this Analysis of amniotic fluid from 163 patients with fetus was successfully treated in utero with cardiac structurally normal fetuses thought to be at low risk supportive therapy (digoxin) (15). for fetal viral infection revealed PCR-positive results
Regardless of the underlying cause, two etiopathoin 13 pregnancies initially. In 9 PCR-positive preggenic mechanisms are thought to underlay the develnancies, the fetus subsequently became clinically affected (e.g., nonimmune hydrops); in 3 of these in utero death occurred. In the remaining unaffected fetuses, only 4/154 (2.6%) were PCR-positive (Table 3).
DISCUSSION
The rapid and accurate identification of an infectious agent in a pregnancy with a sonographic abnormality or the confirmation of transplacental trans- ingly, adenovirus was the most commonly detected opment of nonimmune fetal hydrops as a final comexpected that a significant percentage of pregnant women will contract a primary infection without any mon pathway: (1) cardiac failure and (2) anemia (10) (11) (12) (13) . The significance of cardiac failure in nonimmeasurable direct pathological effect even with transmission of the virus to the fetus. Importantly, mune hydrops was previously suggested by RuizVillaespesa (64) and has now been directly demonmore than 50% of mothers with known infections were PCR-positive (usually CMV or adenovirus) in strated by the measurement of umbilical venous pressures during diagnostic cordocentesis (11) and this study and a substantial percentage of their fetuses had postnatal abnormalities or fetal demise. indirectly by the measurement of the cardiothoracic index during prenatal ultrasound examination.
This strengthens the likelihood of causation. The assessment of the role of these viruses in pregnancy Based on these approaches, cardiac failure appears more common than previously suggested (11, 64) . In requires further systematic investigations of large numbers of fetuses at risk, as well as pregnancies the majority of cases, cardiac failure is explained by structural anomalies, compression by cardiac or not thought to be at significant risk for either primary fetal disease or intrauterine infection. extracardiac intrathoracic tumors, or other reasons for impaired venous return (11, 12, 13, 64) . OccasionSome of the fetuses studied had evidence of multiple viral genomes by PCR. In a high percentage of ally, a fetal tachyarrhythmia of unknown underlying etiology is present (10, 12, 13) . We speculate that in these cases the fetus was either severely affected or the pregnancy ended with in utero demise. The a substantial proportion of these fetuses, as well as in the 22% (12) of those fetuses classified as ''idiopotential relevance of the molecular identification of viral genome(s) to disease is speculative, but the pathic'' nonimmune hydrops, an unrecognized fetal myocarditis affecting myocardial contractility or the identification of multiple genomes appears to be a poor prognostic indicator. Larger patient numbers conduction system is the origin of the cardiac failure. It is well documented that a rhythm disturbance are required for study in order to clarify this relationship as speculation or fact. may be the presenting finding of myocarditis postnatally.
Since PCR is a very sensitive technique the possibility of false positive results must be considered. The relative frequency of the individual viral genomes amplified from the clinical specimens in this Strict criteria and compulsive technique are required for the prevention of contamination of the study differs from previous fetal and neonatal studies which analyzed fetuses by culture and serologic samples under study. All studies in the present investigation included positive and negative control methods. Studies using more sophisticated molecular analysis focused only on CMV and parvovirus.
samples for each amplification, as well as amplification of a constitutive human gene for evaluation of Recent studies of fetuses and children with myocarditis have demonstrated results similar to those rethe nucleic acid extraction method, and the confirmation of results with Southern blotting (51), liquid ported here (15, 42, 65) . In addition, viral genome was found in fetal conditions not formerly believed to be hybridization techniques (52), and/or direct sequencing (53) . We believe these efforts minimize the likeliassociated with viral infection. For example, adenoviral genome was found in some fetuses with intrahood of laboratory error as an explanation for our findings. cranial findings such as ventriculomegaly, and adenovirus and enterovirus were found in a significant
In conclusion, viral genomic material is commonly associated with abnormal pregnancies. Our data number of fetuses with a ''stuck twin'' syndrome. The exact significance of these results remains at this suggest that viral infection may have a much larger role in fetal pathology than previously noted. Future time speculative. However, the significant increase in prevalence of positive PCR results in abnormal studies should include analyses for the viruses outlined in this report, as well as other candidates for pregnancies compared to amniotic fluid samples from uncomplicated pregnancies suggests a causfetal disease, such as the newly identified human herpes virus 6 which appears to cause disease in ative association. Additional support for a causative association is provided by the nine pregnancies iniinfants and young children (66) . In addition, McLean et al. (67) evaluated 243 amniotic fluid specimens tially considered to be at low risk for viral infection (i.e., control patients) in whom a PCR-positive result obtained from low risk pregnancies for adenovirus, CMV, parvovirus, and HSV using PCR and found no preceded fetal disease. Adenovirus and enterovirus are both common in the population and it may be amplification of viral genome. This work supports 
